Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir

被引:38
作者
Suzutani, T
Ishioka, K
De Clercq, E
Ishibashi, K
Kaneko, H
Kira, T
Hashimoto, K
Ogasawara, M
Ohtani, K
Wakamiya, N
Saijo, M
机构
[1] Fukushima Med Univ, Dept Microbiol, Fukushima 9601295, Japan
[2] Asahikawa Med Coll, Dept Microbiol, Asahikawa, Hokkaido 078, Japan
[3] Natl Inst Infect Dis, Dept Special Pathogen Lab, Tokyo, Japan
[4] Rega Inst, B-3000 Louvain, Belgium
关键词
D O I
10.1128/AAC.47.5.1707-1713.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 21 clones of acyclovir (ACV)-resistant (ACV) herpes simplex virus type 1 (HSV-1) and 23 clones of penciclovir (PCV)-resistant (PCVr) HSV-1, emerging during serial passages in the presence of ACV or PCV, were isolated under conditions excluding contamination of resistant mutants in the starting virus culture, and their mutations in the thymidine kinase (TK) and DNA polymerase (DNA Pol) genes were analyzed comparatively. Mutations in the TK genes from ACV(r) mutants consisted of 50% single nucleotide substitutions and 50% frameshift mutations, while the corresponding figures for the PCVr mutants were 4 and 96%, respectively (P<0.001). Eight of the 21 ACV(r) clones, but none of the 23 PCVr clones, had mutations in DNA Pol. Only nucleotide substitution(s) could be detected in the DNA Pol gene, as the gene is essential for virus replication. Therefore, the results for the DNA Pol mutants are concordant with those for the TK mutants in that a single nucleotide substitution was commonly observed in the ACV(r), but not in the PCVr, mutants. These results clearly point to differential mutation patterns between ACV(r) and PCVr HSV-1 clones.
引用
收藏
页码:1707 / 1713
页数:7
相关论文
共 38 条
[1]   RESISTANCE OF HERPES-SIMPLEX TO ACYCLOVIR [J].
BALFOUR, HH .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (03) :404-406
[2]   BIOCHEMICAL AND GENETIC-ANALYSIS OF ACYCLOVIR-RESISTANT MUTANTS OF HERPES-SIMPLEX VIRUS TYPE-1 [J].
COEN, DM ;
SCHAFFER, PA ;
FURMAN, PA ;
KELLER, PM ;
STCLAIR, MH .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (1A) :351-360
[3]  
COLLINS P, 1988, AM J MED, V85, P129
[4]  
DERSE D, 1981, J BIOL CHEM, V256, P1447
[5]  
DETEMA R, 1987, ANTIVIR RES, V7, P303
[6]  
DOWDLE WR, 1967, J IMMUNOL, V99, P974
[7]   MODE OF ANTIVIRAL ACTION OF PENCICLOVIR IN MRC-5 CELLS INFECTED WITH HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1), HSV-2, AND VARICELLA-ZOSTER VIRUS [J].
EARNSHAW, DL ;
BACON, TH ;
DARLISON, SJ ;
EDMONDS, K ;
PERKINS, RM ;
HODGE, RAV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2747-2757
[8]   HERPES-SIMPLEX VIRUS RESISTANT TO ACYCLOVIR - A STUDY IN A TERTIARY CARE CENTER [J].
ENGLUND, JA ;
ZIMMERMAN, ME ;
SWIERKOSZ, EM ;
GOODMAN, JL ;
SCHOLL, DR ;
BALFOUR, HH .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :416-422
[9]   INHIBITION BY ACYCLOVIR OF CELL-GROWTH AND DNA-SYNTHESIS OF CELLS BIOCHEMICALLY TRANSFORMED WITH HERPESVIRUS GENETIC INFORMATION [J].
FURMAN, PA ;
MCGUIRT, PV ;
KELLER, PM ;
FYFE, JA ;
ELION, GB .
VIROLOGY, 1980, 102 (02) :420-430
[10]   Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients [J].
Gaudreau, A ;
Hill, E ;
Balfour, HH ;
Erice, A ;
Boivin, G .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (02) :297-303